Bristol-Myers Squibb

Beyond the Blockbuster: How Strategic Outsourcing is Redefining Oncology Target Discovery The era of the pharmaceutical behemoth acting as a closed-circuit innovation hub is dead. For decades, the industry standard was to keep research behind locked doors, but a seismic shift is underway as Big Pharma realizes that the next breakthrough in cancer treatment won’t … Read more